prevention

A judge on Tuesday blocked the Trump administration from requiring recipients of federal teen pregnancy prevention grants to comply with the president’s orders aimed at curtailing “radical indoctrination” and “gender ideology.”

The ruling is a victory for three Planned Parenthood affiliates — in California, Iowa and New York — that sued to try to block enforcement of a U.S. Department of Health and Human Services policy document issued in July that they contend contradicts the requirements of the grants as established by Congress.

U.S. District Judge Beryl Howell, who was appointed to the bench by former President Obama, blasted the administration’s policy change in her written ruling, saying it was “motivated solely by political concerns, devoid of any considered process or analysis, and ignorant of the statutory emphasis on evidence-based programming.”

The policy requiring changes to the pregnancy prevention program was part of the fallout from a series of executive orders Trump signed starting in his first day back in the White House aimed at rolling back recognition of LGBTQ+ people and diversity, equity and inclusion efforts.

In the policy, the administration objected to teaching that promotes same-sex marriage and that “normalizes, or promotes sexual activity for minors.”

The Planned Parenthood affiliates argued that the new directives were at odds with the requirements of the program — and that they were so vague it wasn’t clear what needed to be done to follow them.

Howell agreed.

The decision applies not only to the handful of Planned Parenthood groups among the dozens of recipients of the funding, but also to nonprofit groups, city and county health departments, Native American tribes and universities that received grants.

The Health and Human Services Department, which oversees the program, declined to comment on Tuesday’s ruling. It previously said the guidance for the program “ensures that taxpayer dollars no longer support content that undermines parental rights, promotes radical gender ideology, or exposes children to sexually explicit material under the banner of public health.”

Mulvihill writes for the Associated Press.

WASHINGTON — The U.S. is purchasing enough doses of a new twice-a-year HIV prevention shot to share with up to 2 million people in poor countries by 2028, the State Department announced Thursday.

Gilead Sciences had already announced it would sell that supply of the protective drug lenacapvir at no profit for use in low- and middle-income countries that are hard-hit by HIV. The question was who would buy and distribute it after the Trump administration slashed foreign aid earlier this year — forcing closures of health clinics and disrupting HIV testing and care in many countries.

Under Thursday’s move, the U.S. will purchase the doses under the PEPFAR program and work with governments in hard-hit countries on how to distribute them. The priority will be to protect pregnant or breastfeeding women, said Jeremy Lewin, a State Department senior official.

Lewin said the program will be a collaboration with the Global Fund, another international program that funds HIV treatment and prevention efforts, but wouldn’t disclose how much the U.S. was investing.

“We’re hoping, with the Global Fund, to help 2 million people get on the medication over the next three years but could potentially see more,” he said.

There are more than 30,000 new HIV infections in the U.S. every year and 1.2 million people are living with the virus. Worldwide there are 1.3 million new infections annually and nearly 40 million people living with the virus.

Many experts say lenacapavir is the most powerful option yet for what’s called PrEP — using preventive medicines to guard against sexually transmitted HIV. Unlike daily pills that people may forget, each lenacapavir shot offers protection for six months. In two groundbreaking studies with people at high risk, it nearly eliminated new infections.

The drug already has been approved for use in the U.S. and Europe.

In March, the head of the U.N. AIDS agency urged the Trump administration and Gilead to make the preventive shots available worldwide for millions.

Gilead has signed agreements with generic drugmakers to produce low-cost versions of the shot for poor countries, mostly in Africa, Southeast Asia and the Caribbean. The doses provided at-cost for up to 2 million people in those countries were intended to be a stopgap until the generics are available.

Neergaard writes for the Associated Press.

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, following an outcry from HIV prevention organizations, health experts and Democrats in Congress.

The Los Angeles County Department of Public Health received notice from the U.S. Centers for Disease Control and Prevention on Thursday that it had been awarded nearly $20 million for HIV prevention for the 12-month period that began June 1 — an increase of $338,019 from the previous year.

“Let’s be clear — the Trump administration’s move to freeze HIV prevention funding was reckless, illegal and put lives at risk,” said Rep. Laura Friedman (D-Glendale) in a statement. “I’m relieved the CDC finally did the right thing — but this never should have happened.”

The CDC didn’t immediately respond to a request for comment.

Friedman and other advocates for HIV prevention funding sent a letter to Health and Human Services Secretary Robert F. Kennedy Jr. last month, warning that proposed cuts to these programs would reverse years of progress combating the disease and cause spikes in new cases — especially in California and among the LGBTQ+ community.

The letter cited estimates from the Foundation for AIDS Research, known as amfAR, suggesting the cuts could lead to 143,000 additional HIV infections nationwide and 127,000 additional deaths from AIDS-related causes within five years.

Los Angeles County, which stood to lose nearly $20 million in annual federal HIV prevention funding, was looking at terminating contracts with 39 providers. Experts said the dissolution of that network could result in as many as 650 new cases per year — pushing the total number of new infections per year in the county to roughly 2,000.

“Public Health is grateful for the support and advocacy from the Board of Supervisors, the Los Angeles County Congressional delegation, and all of our community based providers in pushing CDC to restore this Congressionally approved funding,” a spokeswoman for the county’s health department said.

“Looking forward, it is important to note that the President’s FY26 budget proposes to eliminate this funding entirely, and we urge our federal partners to support this critical lifesaving funding,” she said.

SAN FRANCISCO — A federal judge in California has blocked the Trump administration from enforcing anti-diversity and anti-transgender executive orders in grant funding requirements that LGBTQ+ organizations say are unconstitutional.

U.S. District Judge Jon Tigar said Monday that the federal government cannot force recipients to halt programs that promote diversity, equity and inclusion or acknowledge the existence of transgender people in order to receive grant funding. The order will remain in effect while the legal case continues, although government lawyers will likely appeal.

The funding provisions “reflect an effort to censor constitutionally protected speech and services promoting DEI and recognizing the existence of transgender individuals,” Tigar wrote.

He went on to say that the executive branch must still be bound by the Constitution in shaping its agenda and that even in the context of federal subsidies, “it cannot weaponize Congressionally appropriated funds to single out protected communities for disfavored treatment or suppress ideas that it does not like or has deemed dangerous.”

The plaintiffs include health centers, LGBTQ+ services groups and the Gay Lesbian Bisexual Transgender Historical Society. All receive federal funding and say they cannot complete their missions by following the president’s executive orders.

The San Francisco AIDS Foundation, one of the plaintiffs, said in 2023 it received a five-year grant from the Centers for Disease Control and Prevention to expand and enhance sexual health services, including the prevention of sexually transmitted infections. The $1.3 million project specifically targets communities disproportionately affected by sexual health disparities.

But in April, the CDC informed the nonprofit that it must “immediately terminate all programs, personnel, activities, or contracts” that promote DEI or gender ideology.

President Trump has signed a flurry of executive orders since taking office in January, including ones to roll back transgender protections and stop DEI programs. Lawyers for the government say that the president is permitted to “align government funding and enforcement strategies” with his policies.

Plaintiffs say that Congress — and not the president — has the power to condition how federal funds are used, and that the executive orders restrict free speech rights.

Har writes for the Associated Press.